Robot model
LIBERTY Endovascular Robotic System
Microbot Medical is a Hingham, MA-based commercial-stage medical device company (Nasdaq: MBOT) that developed the LIBERTY Endovascular Robotic System, the…
- Manufacturer
- Microbot Medical
- Form factor
- surgical
- Maturity
- commercial
- Lifecycle
- active
- Deployments
- 5
- Website
- ir.microbotmedical.com ↗
The verified answer
As of Oct 2026, DEPLOY verifies LIBERTY Endovascular Robotic System, a surgical by Microbot Medical (commercial): 5 verified deployments on record. 3 sources back the record.
Overview
Microbot Medical is a Hingham, MA-based commercial-stage medical device company (Nasdaq: MBOT) that developed the LIBERTY Endovascular Robotic System, the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The LIBERTY system received FDA 510(k) clearance in 2025.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Sources on file
- View all sources →
Key facts
FDA cleared
Stock
Product
FDA clearance
Key feature
Ticker
Category
FDA 510(k) clearance
Single-use remote operation
Full market release
Data & sources
Press releases
3
3 sources backing this record.View all →
Pricing
No verified price is on record for LIBERTY Endovascular Robotic System. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Deployments (5)
First healthcare system in North Carolina to adopt the LIBERTY Endovascular Robotic System.
Tampa General Hospital — first health system in Florida to adopt the LIBERTY system.
Emory Healthcare — first hospital in the world to adopt the LIBERTY system.
Microbot Medical partnered with Baptist Hospital of Miami as the second clinical trial site for the LIBERTY pivotal human clinical trial.
First procedure in a patient using the LIBERTY endovascular robotic surgical system performed by Dmitry Rabkin, MD at Brigham and Women's Hospital as part of the pivotal clinical trial.
LIBERTY Endovascular Robotic System on the deployment map
View the global mapWhere LIBERTY Endovascular Robotic System is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 2, 2026
Added to the verified registry
- Deployment verifiedVerifiedMay 1, 2026
at North Carolina, USA
- Deployment verifiedVerifiedMar 26, 2026
at Atlanta, Georgia, USA
- Deployment verifiedVerifiedMar 2, 2026
at Tampa, Florida, USA
- Incident recordedSep 8, 2025
Microbot Medical receives FDA 510(k) clearance for Liberty endovascular robotic system
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Incidents affecting LIBERTY Endovascular Robotic System (1)
- Microbot Medical receives FDA 510(k) clearance for Liberty endovascular robotic system2025-09-08 · Regulatory action
Includes incidents linked directly to this model or to deployments of it. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Sources (3)
- https://ir.microbotmedical.com/news-events/press-release
- https://ir.microbotmedical.com/news-releases/news-release-details/microbot-medicalr-receives-fda-510k-clearance-its-libertyr
- https://ir.microbotmedical.com/news-releases/news-release-details/microbot-medicalr-commences-full-market-release-fmr-libertyr
Common questions
What is LIBERTY Endovascular Robotic System?
How much does LIBERTY Endovascular Robotic System cost?
Is LIBERTY Endovascular Robotic System actually deployed in the real world?
Who makes LIBERTY Endovascular Robotic System?
Where is LIBERTY Endovascular Robotic System deployed?
Can you buy LIBERTY Endovascular Robotic System?
What are alternatives to LIBERTY Endovascular Robotic System?
How does LIBERTY Endovascular Robotic System compare to da Vinci (and Ion)?
Is LIBERTY Endovascular Robotic System a top surgical?
What is LIBERTY Endovascular Robotic System's maturity stage?
Is LIBERTY Endovascular Robotic System safe?
Methodology: Verified · 3 sources (3 primary) · last reviewed 2026-09-29
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-09-29
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 3
- primary-company-ir
- Company IR disclosure
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for LIBERTY Endovascular Robotic System.Recent coverage
LIBERTY Endovascular Robotic System in third-party press
Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System
Microbot Medical Receives FDA 510(k) Clearance for Its LIBERTY Endovascular Robotic System
Microbot Medical Receives FDA 510(k) Clearance for Its LIBERTY Endovascular Robotic System
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning LIBERTY Endovascular Robotic System from third-party publications. Automatically surfaced; not part of the verified registry record.
Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System
Microbot Medical won the 2026 Innovative Start-Up Award from Surgical Robotics Technology for its FDA-cleared LIBERTY Endovascular Robotic System, now adopted across seven U.S.…
Microbot Medical Receives FDA 510(k) Clearance for Its LIBERTY Endovascular Robotic System
Microbot Medical received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, the first single-use remotely operated endovascular surgical robot.
Microbot Medical Receives FDA 510(k) Clearance for Its LIBERTY Endovascular Robotic System
Microbot Medical received FDA 510(k) clearance for the LIBERTY system, the first single-use remotely operated robotic system for peripheral endovascular procedures.
Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System
Microbot Medical won a surgical robotics industry award for LIBERTY, the only FDA-cleared single-use remotely operated robotic system for peripheral endovascular procedures.
FDA clears Microbot Medical's Liberty endovascular surgical robot
Microbot Medical received FDA 510(k) clearance for its Liberty endovascular surgical robot, the first single-use remotely operated system for peripheral endovascular procedures.
Machine-readable surfaces
- Markdown mirror: /models/liberty-endovascular.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/cd51c658-641a-4d09-b0ac-57aaf6874f42
- Revision history: /models/liberty-endovascular/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
LIBERTY Endovascular Robotic System draws attention at the 27th percentile but verifies reality at the 83rd percentile among surgical robots. Hype Gap -55.9, 45th widest among surgical robots.
6-month trend
Analysis
Limited independent press and video coverage to date.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Oct 2, 2026